Comparison Between Implanted Functional Electrical Stimulation and Foot Orthosis

NCT ID: NCT01415700

Last Updated: 2014-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

27 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-10-31

Study Completion Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The implantable feet stimulator proposes to correct the feet's STEPPAGE observed after central nervous system's injury such as hemiplegia secondary to stroke. It aims to improve the patient's walking floor by removing the STEPPAGE, reducing the effort of walking, facilitating the flow and removing anomalies compensatory (such as the mowing of the hip). Its objective is to improve the patient's autonomy locomotor.

The aim of this study is to compare the results of the implementation of an implanted stimulator in the levator muscles of the foot to the results obtained by wearing a splint-type reliever, which is considered standard treatment, in order to determine if the implanted stimulation may be proposed in the treatment of foot drop off a neurological center.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The implantable feet stimulator proposes to correct the feet's STEPPAGE observed after central nervous system's injury such as hemiplegia secondary to stroke. It aims to improve the patient's walking floor by removing the STEPPAGE, reducing the effort of walking, facilitating the flow and removing anomalies compensatory (such as the mowing of the hip). Its objective is to improve the patient's autonomy locomotor.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hysterical Simulation of Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stimulator

Group Type EXPERIMENTAL

Functional electrical stimulator

Intervention Type DEVICE

The stimulator is surgically implanted

Orthosis

Group Type ACTIVE_COMPARATOR

feet orthosis

Intervention Type DEVICE

feet orthosis specifically mold

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Functional electrical stimulator

The stimulator is surgically implanted

Intervention Type DEVICE

feet orthosis

feet orthosis specifically mold

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* STEPPAGE foot walking in a patient with a central neurological disease
* can walk for 50 meters with or without technical assistance
* stable disease for at least 1 year
* possible walk with a brace-type reliever
* verification of possible nerve stimulation
* age greater than or equal to 18 years and under 75 years
* no toxin for 4 months
* no alcohol for 6 months
* no neurotomy for 1 year
* patient who agreed to sign an informed consent to participate in the study

Exclusion Criteria

* cons-indication to general anesthesia
* wearing a stimulator implanted for other reasons
* patients taking neuroleptics, benzodiazepines, or antidepressants or other drugs that interfere with the quality of walking
* advanced peripheral neuropathy
* excessive restriction of passive range of ankle
* poorly controlled epilepsy
* pregnant or lactating
* non-membership of a social security scheme
* wearing orthopaedic shoes including the malleolus
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Philippe Decq, PUPH

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Henri Mondor Hospital

Créteil, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2007-A01444-49

Identifier Type: OTHER

Identifier Source: secondary_id

P070155

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Transfemoral Powered Foot and Physical Therapy Study
NCT03625921 ACTIVE_NOT_RECRUITING NA
1C70 Feasibility Study
NCT05628064 COMPLETED NA